POCL uses Rs 56.3096846 crore of equity proceeds, capex pending

POCL Enterprises Limited used Rs 56.3096846 crore of the Rs 58.2996846 crore raised through preferential equity shares by September 30, 2026, leaving Rs 1.99 crore of capital-expenditure funds invested in a money-market instrument. POCL reported no deviation or variation from the approved uses for the June 18, 2025 fund raise.

How much of POCL's preferential equity issue has been used?

POCL used Rs 56.3096846 crore of its Rs 58.2996846 crore preferential equity-share proceeds as at September 30, 2026. The company raised the amount on June 18, 2025 through the allotment of 28,86,123 equity shares at Rs 202 each, and its utilisation statement reported nil deviation for every approved object.

Working capital was the largest use at Rs 33.50 crore, followed by Rs 19 crore for organic and inorganic growth opportunities and strategic acquisitions. POCL also used Rs 2.4996846 crore for general corporate purposes and Rs 1.31 crore for capital expenditure, covering the four purposes set out in the equity-share issue.

The comparison shows that the growth, working-capital and general-corporate allocations were fully used, while the Rs 3.30 crore capex allocation was only partly deployed. The Rs 1.99 crore difference between the capex allocation and utilisation was still pending final use at September 30, 2026, although POCL recorded no deviation for the capex line.

Why is POCL's Rs 1.99 crore capex balance invested?

POCL said the Rs 1.99 crore capex balance remained invested in a money-market instrument at September 30, 2026. The company initially invested the full Rs 3.30 crore capex allocation in that instrument as an interim use, then redeemed Rs 1.31 crore for use toward approved objects.

The approved capital-expenditure object includes plant and machinery, equipment, manufacturing units, buildings, land, and the refurbishment or renovation of company assets. POCL said the interim money-market placement was in line with the shareholder approval obtained for the preferential issue; the filing does not identify the capex project, asset, supplier or expected deployment date for the remaining Rs 1.99 crore.

POCL's disclosure defines deviation or variation to include a change in the fundraising object, a difference between actual use and the original disclosure, or a change in fundraising-contract terms. Despite the unspent capex balance, POCL reported nil deviation, said its Audit Committee noted no deviation or variation, recorded nil auditor comments, and stated that no monitoring agency was applicable for the September 30, 2026 report.

How did POCL allocate equity proceeds to growth and working capital?

POCL allocated Rs 52.50 crore of the Rs 58.2996846 crore equity-share proceeds to strategic growth and working-capital requirements, and used the full amount by September 30, 2026. The Rs 19 crore growth allocation and Rs 33.50 crore working-capital allocation together accounted for the largest two categories of the issue.

The strategic-growth object permits organic and inorganic opportunities, including joint ventures, share acquisitions that may result in an associate relationship, mergers, takeovers, slump-sale acquisitions and direct acquisition of business undertakings. POCL reported Rs 19 crore as used under this category but did not name an acquisition, joint venture or undertaking financed from that amount.

The Rs 33.50 crore working-capital object also covers the needs of an undertaking or company acquired through strategic acquisitions, using forms including equity, preference shares, quasi-equity or unsecured loans. POCL did not split the reported Rs 33.50 crore utilisation between its existing operations and any acquired undertaking, while the separate Rs 2.4996846 crore general-corporate allocation was fully used.

What is the status of POCL's preferential warrants?

POCL had received and used Rs 2.8420491 crore from its preferential convertible warrants by September 30, 2026, equal to 25% of their total consideration of Rs 11.3681964 crore. The company allotted 5,62,782 warrants at Rs 202 each on June 18, 2025, separately from the Rs 58.2996846 crore equity-share issue.

Of the total warrant consideration, Rs 3.3682176 crore was allocated to working capital and Rs 7.9999788 crore to capex. POCL reported Rs 2.8420491 crore used for working capital and nil capex use, reflecting that it had received only the initial 25% payment rather than the full warrant consideration.

The remaining 75% of the Rs 11.3681964 crore warrant consideration is due when holders convert the warrants into equity shares, within 18 months from their allotment date. No warrant holder exercised the conversion option during the quarter ended September 30, 2026, and POCL separately reported nil deviation in its use of warrant proceeds.

Conclusion

POCL's September 30, 2026 filing shows that almost all preferential equity-share proceeds had been deployed: Rs 56.3096846 crore out of Rs 58.2996846 crore. Working capital absorbed Rs 33.50 crore and growth or acquisition purposes absorbed Rs 19 crore, while the only balance was Rs 1.99 crore of capex money held in a money-market instrument.

The next disclosed developments to watch are final utilisation of the Rs 1.99 crore capex balance and warrant conversions within the stated 18-month period from allotment. Those conversions would determine when POCL receives the remaining 75% of the Rs 11.3681964 crore warrant consideration and whether further funds are available for the Rs 7.9999788 crore warrant-linked capex allocation.